Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

BZAM Ltd. is a premium certified organically grown cannabis company focused on the health and wellness market. Its organic cannabis is cultivated in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. In Canada, BZAM sells dried flower and oil, and recently launched a series of next‐generation cannabis products such as hash, vapes, organic teas and dissolvable powders.

C21 Investments Inc. is a vertically integrated cannabis company with newly acquired operations in Nevada and Oregon, U.S.A.  C21’s strategy is to acquire existing cannabis operations in the U.S.A. and globally, with experienced management teams in place.  C21’s focus is to expand where it can wholly own indoor/outdoor cultivation operations, processing/extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

The Camarico Investment Group Ltd. is an innovative investment issuer engaged in the integrated development, acquisition and partnership of intellectual property, assets and portfolio interests.

Trading remains halted pending a fundamental change as described in Policy 8.  The corporate actions announced in this bulletin in no way represent Exchange approval, conditional or otherwise, of the fundamental change transaction.

Canada House Cannabis Group Inc. is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; Canada House Clinics Inc., clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from common to complex medical conditions; IsoCanMed Inc., a Licensed Producer in Louiseville, Quebec, that produces high quality medical grade cannabis; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.

 

 

CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

Investor Note: In addition to the 213,211,781 common shares that are listed and trading, there are 5,700,000 reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 218,911,781.

Cannibble is a food-tech company that develops and manufactures food and beverage products that are enhanced variously with hemp seeds, hemp protein, and other hemp ingredients, where legal to do so. Cannibble has developed proprietary formulas for food and beverages products that are enhanced with hemp seeds and protein, targeted for the “Better For You” segment. The products are sugar free, dairy free, plant based and non GMO, and marketed under Cannibble’s brand name “The Pelicann”.

Cannibble has developed over 100 product SKUs, of which 40 have been manufactured to date.

Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.

Cansortium Inc. is a vertically-integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the Fluent™ brand and is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by Cansortium's unrelenting commitment to operational excellence in cultivation, production, distribution and retail. The Company is headquartered in Miami, Florida.  For more information please visit www.getfluent.com.

Investor Note: In addition to the 270,236,670 Common Shares that are listed and trading, there are 2,607,724 Proportionate Voting Shares, convertible into Common Shares at a ratio of 1:10, that are issued and outstanding but not listed. The total number of issued shares, assuming all are converted into the listed class, would be 296,313,910.

CBD Global Sciences Inc., dba Global Sciences (CSE: CBDN)  (OTC: CBDNF)(Frankfurt: GS3.F) (Munich: GS3.MU), is a multi-faceted international company focused on brand development, product distribution, and consultation for new companies that need market recognition and new sales.

Global Sciences, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC, and Legacy Distribution Group, is delivering products both in retail and e-commerce formats.  The Direct Store Distribution (DSD) provides exclusive distribution services for over 90 vendors of Beverage and Snack products throughout the Colorado and Wyoming territories, currently servicing over 5,000 stores, both large and small formats. Known by the industry as the ‘go to’ for brand introduction, the DSD Operations have played a critical role in most all new beverage brands introduced to the market over the past 20 years, including brand names like Xing Tea, Monster, Rockstar, Vitamin Water, Smart Water, NOS, Fuze, Nantucket Nectars, Muscle Milk, Izze, Celsius, C4, and many others.

In addition to Legacy Distribution Group, it has added a manufacturing division to enhance its Supply Chain.  Resinosa LLC, provides capabilities with cGMP manufacturing of confectionary and snack products with both private label and white label capabilities.  As part of the Manufacturing Division, Aspen Pure Bottling enhances the company's ability to quickly develop and distribute new beverage brands offering a “one-stop-shop” solution for brand creation and market penetration.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

TAKESTOCK - Calgary Investor Forum

TAKESTOCK - Calgary Investor Forum

Wednesday, June 7, 2023 -
9:00am to 5:00pm
Summit on Responsible Investment

Summit on Responsible Investment

Tuesday, June 27, 2023 -
9:00am to 7:00pm

Advertisement

Publicité